Vernalis (VER)

 

Latest News

Block listing Interim Review

RNS Number: 2209L Vernalis PLC 29 September 2016 BLOCK LISTING SIX MONTHLY RETURN VERNALIS PLC (the "Company") 29 September 2016 Vernalis plc (LSE: VER) provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements: Name of applicant: Vernalis plc Name o...

Broker Forecast - Canaccord Genuity issues a broker note on Vernalis PLC

Canaccord Genuity today reaffirms its buy investment rating on Vernalis PLC (LON:VER) and raised its price target to 8...

Vernalis widens FY post-exceptionals pretax loss

Vernalis has widened its FY post-exceptionals pretax loss to 15.3m, from a year-earlier loss of 3.7m. Revenue was lower at 12...

Results Announcement for 12 months ended 30/06/16

RNS Number: 1414L Vernalis PLC 29 September 2016 29 September 2016 LSE: VER Vernalis plc Results Announcement for the 12 months ended 30 June 2016 Significant investment in Tuzistra XR US launch as transition to a commercial specialty pharmaceutical company continues Vernalis plc (LSE: VER) today announces its audited results for the 12 month period...

All News

DateHeadlineSource
29-09-16Block listing Interim ReviewRNS
29-09-16Broker Forecast - Canaccord Genuity issues a broker note on Vernalis PLCStockMarketWire
29-09-16Vernalis widens FY post-exceptionals pretax lossStockMarketWire
29-09-16Results Announcement for 12 months ended 30/06/16RNS
22-09-16Holding(s) in CompanyRNS
14-09-16Holding(s) in CompanyRNS
13-09-16Vernalis schedules FY results StockMarketWire
13-09-16Notice of ResultsRNS
06-09-16Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
06-09-16Vernalis says FDA accepts CCP-07 NDA for full reviewStockMarketWire
06-09-16FDA accepts CCP-07 NDA for full reviewRNS
29-07-16Total Voting RightsRNS
26-07-16Holding(s) in CompanyRNS
19-07-16Vernalis achieves oncology milestone with ServierStockMarketWire
19-07-16Vernalis Achieves Oncology Milestone with ServierRNS
15-07-16Vernalis notes RedoxTherapies acquisition by JunoStockMarketWire
15-07-16Vernalis Notes RedoxTherapies Acquisition by JunoRNS
08-07-16Vernalis Announce CCP-08 Multiple-Dose ResultsRNS
07-07-16Year-end Trading Update and Notice of ResultsRNS
30-06-16Total Voting RightsRNS
24-06-16Holding(s) in CompanyRNS
09-06-16Director Deals - Vernalis PLC (VER)StockMarketWire
09-06-16Director Deals - Vernalis PLC (VER)StockMarketWire
09-06-16Director DealingRNS
31-05-16Total Voting RightsRNS
19-05-16Moxatag Supply UpdateRNS
16-05-16Holding(s) in CompanyRNS
12-05-16Broker Forecast - Canaccord Genuity issues a broker note on Vernalis PLCStockMarketWire
12-05-16Vernalis passes AGM resolutionsStockMarketWire
12-05-16Results of General MeetingRNS
29-04-16Total Voting RightsRNS
27-04-16Holding(s) in CompanyRNS
26-04-16Posting of Circular and Notice of General MeetingRNS
26-04-16Vernalis announces GB40m placing at 50p/shareStockMarketWire
26-04-16Vernalis plc to raise ?40 million in PlacingRNS
21-04-16Vernalis Therapeutics COO appointed StockMarketWire
21-04-16Sandford Sommer appointed as President & COO in USRNS
14-04-16Vernalis issues CCP-07 multiple-dose results StockMarketWire
14-04-16Vernalis Announce CCP-07 Multiple-Dose ResultsRNS
13-04-16VER announces CCP-08 single-dose study results StockMarketWire

RSS feeds

  • Editorial news feed for LSE:VER Editorial
  • Regulatory news feed for LSE:VER Regulatory